Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Net Cash Flow (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Net Cash Flow for 10 consecutive years, with $2.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Net Cash Flow rose 138.5% to $2.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$24.5 million, a 289.59% decrease, with the full-year FY2025 number at -$24.5 million, down 289.59% from a year prior.
  • Net Cash Flow was $2.7 million for Q4 2025 at Orthopediatrics, up from -$27.7 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $25.8 million in Q1 2023 to a low of -$27.7 million in Q3 2025.
  • A 5-year average of -$463950.0 and a median of -$362500.0 in 2022 define the central range for Net Cash Flow.
  • Peak YoY movement for Net Cash Flow: tumbled 1668.57% in 2022, then skyrocketed 2082.01% in 2024.
  • Orthopediatrics' Net Cash Flow stood at $1.7 million in 2021, then crashed by 1668.57% to -$26.6 million in 2022, then skyrocketed by 174.3% to $19.8 million in 2023, then tumbled by 135.11% to -$6.9 million in 2024, then soared by 138.5% to $2.7 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Net Cash Flow are $2.7 million (Q4 2025), -$27.7 million (Q3 2025), and $10.8 million (Q2 2025).